Page results
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
File results
-
FOI/2024/0076 - Patient Portal contract and supplier
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0079 - Water procurement
-
FOI/2024/0080 - Patient treatment for botched non-surgical procedures
-
FOI/2024/0094 - Record Freedom of Information data 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0096 - Waiting lists for gynaecology treatment 2021-2024
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract